News August 22, 2024 Wexford Laboratories launches a new product, Ondansetron 4 mg/2 mL Injectable Solution, driven by high demand projections according to studies. READ MORE March 24, 2024 Dexketoprofen 50mg/2ml Injectable Solution: A New Option for Pain Relief READ MORE December 11, 2023 Wexford announces approval of In Vitro Bioequivalence READ MORE May 19, 2021 Expansion of our plants to comply with new regulations in high-regulatory markets READ MORE Previous 1 2 3 4 Next
